The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells: Molecular characterization and evidence for functional coupling to the thrombin receptor

Journal of Clinical Investigation

Volumn 97, Issue 7, 1996, Pages 1705-1714

  Mirza, Humayun ^a   Yatsula, Victoria ^a   Bahou, Wadie F ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

calcium; cell signaling; desensitization; G proteins; seven transmembrane receptors

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BRADYKININ; CALCIUM; CELL RECEPTOR; COMPLEMENTARY DNA; COMPLEMENTARY RNA; ENDOTHELIN 1; FURA 2; OLIGONUCLEOTIDE; PROTEINASE ACTIVATED RECEPTOR 2; THROMBIN; THROMBIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INTERNALIZATION; MITOGENICITY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; XENOPUS;

EID: 0030003829     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118597     Document Type: Article

References (55)

1. Vu, T., D. Hung, V. Wheaton, and S. Coughlin. 1991 Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1057-1068.
2. Ngaiza, J., and E. Jaffe. 1992. A 14 amino acid peptide derived from the amino terminus of the cleaved thrombin receptor elevates intracellular calcium and stimulates piostacyclin production in human endothelial cells. Biochem Biophys Res. Commun. 179:1656-1661.
3. Zhong, C., D. Hayzer, M. Corson, and M. Runge. 1992. Molecular cloning of the rat vascular smooth muscle thrombin receptor. Evidence for in vivo regulation by basic fibroblast growth factor. J. Biol. Chem 267:16975-16979.
4. Vu, T., V. Wheaton, D. Hung, I. Charo, and S. Coughlin. 1991. Domains specifying thrombin-receptor interaction. Nature (Lond ). 353:674-677.
5. Chen, J., M. Ishii, L. Wang, K. Ishii, and S.R Coughlin. 1994. Thrombin receptor activation. Confirmation of the intramolecular tethered liganding hypothesis and discovery of an alternative intermolecular liganding mode. J. Biol. Chem. 269:16041-16045.
6. Coller, B.S., P. Ward, M. Ceruso, L.E. Scudder, K. Springer, J. Kutok, and G.D. Prestwich. 1992. Thrombin receptor activating peptides importance of the N-terminal serine and its ionization state as judged by pH-dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M. Biochemistry. 31:11713-11720.
7. Scarborough, R., M. Naughton, W. Teng, D. Hung, J. Rose, T. Vu, V. Wheaton, C. Turck, and S. Coughlin. 1992. Tethered ligand agonist peptides: structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function. J. Biol. Chem. 267 13146-13149.
8. Vassallo, R.R., Jr., T. Kieber-Emmons, K. Cichowski, and L.F. Brass. 1992. Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides. J. Biol. Chem. 267:6081-6085.
9. Bahou, W., J. Kutok, A. Wong, C. Potter, and B Coller. 1994. Identification of a thrombin receptor sequence specifying activation-dependent responses. Blood. 84.4195-4202.
10. Gerstzen, R.E., J. Chen, M. Ishii, K. Ishii, L. Wang, T. Nanevicz, C.W. Turck, T.H. Vu, and S.R. Coughlin. 1994. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature (Lond.). 368: 648-651.
11. Liotta, L A., P.S. Steeg, and W.G. Stetler-Stevenson. 1991. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64-327-336.
12. Reich, R., E. Thompson, Y. Iwamato, G.R. Martin, J.R. Geason, G.C. Fuller, and R. Muskin. 1988. Effects of inhibitors of plasminogen activator, serine proteinases and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res. 48:3307-3312.
13. Wang, M., and M-E Stearns. 1988 Blocking of collagenase secretion by astamustine during in vitro turnover and cell invasion. Cancer Res. 48:6262-6271.
14. Dano, K., P.A. Andreason, J. Grondehl-Hansen, P. Kristensen, L.S. Nielsen, and L. Shriver. 1985. Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res. 44:139-266.
15. Estreicher, A., A. Wohlwend, D. Belin, W.D. Schleuring, and J.D. Vassalli. 1989. Characterization of the cellular binding site for the urokinase-type plasminogen activator. J. Biol. Chem. 264:1180-1189.
16. Axelrod, J.H., R. Reich, and R. Mishkin. 1989. Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells. Mol. Cell Biol 9:2133-2141.
17. Martin, S.J., and D.R. Green. 1995. Protease activation during apoptosis: death by a thousand cuts? Cell 82:349-352.
18. Chang, W.C., G.Y. Shi, Y.H. Chow, L.C. Chang, J.S. Hau, M.T. Lin, C.J. Jen, L.Y. Wing, and H.L. Wu. 1993. Human plasmin induces a receptor-mediated arachidonate release coupled with G proteins in endothelial cells. Am. J. Physiol. 264.C271-C281.
19. 2 cells. Proc. Natl. Acad. Sci. USA 88:4382-4385.
20. Shuman, M.A. 1988. Thrombin cellular interactions. Ann. NY Acad. Sci. 485:228-239.
21. Davey, M.E., and S.R. Luscher. 1967. Actions of thromin and other coagulant and proteolytic enzymes on platelets. Nature (Lond.) 216 857-858.
22. Weksler, B.B., C.W. Ley, and E.A. Jaffe. 1978. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A23187. J. Clin. Invest. 62:923-930.
23. Nagy, Z., K. Kolev, E, Csonka, M. Pek, and R. Machovich. 1995. Contraction of human brain endothelial cells by thrombogenic and fibronolytic factors. An in vitro cell culture model. Stroke. 26:265-270
24. Bahou, W., B. Coller, C. Potter, K. Norton, J. Kutok, and M. Goligorsky 1993. The thrombin receptor extracellular domain contains sites crucial for peptide ligand-induced activation. J. Clin Invest. 91:1405-1413.
25. Chaikoff, E.L., R. Caban, C. Yan, and M.S Runge. 1995. Growth-related responses in arterial smooth muscle cells are arrested by thrombin receptor antisense sequences. J. Biol. Chem. 270:7431-7436.
26. McNamara, C.A., I.J Sarembock, L.W. Gimple, J.W. Fenton II, S.R. Coughlin, and G.K. Owens. 1993. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 91:94-98.
27. Glenn, K.C., D.H. Carney, J.W. Fenton, and D.D. Cunningham. 1980. Thrombin active site regions are required for fibroblast receptor binding and initiation of cell division. J. Biol. Chem. 255.6609-6616.
28. Chen, L.B., and J.M. Buchanan. 1975. Mitogenic activity of blood components. I. Thrombin and prothrombin. Proc. Natl. Acad. Sci. USA. 72:131-135.
29. Pohjanpelto, P. 1978. Stimulation of DNA synthesis in human fibroblasts by thrombin. J. Cell. Physiol. 95:189-194.
30. Carney, D.H., R. Mann, W.R. Redin, S.D. Pernia, D. Berry, J.P. Heggers, P.G Hayward, M.C. Robson, J. Christie, and C.J. Annable, et al. 1992. Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J. Clin. Invest. 89:1469-1477.
31. Tesfamariam, B., G.T. Allen, D. Normandin, and M.J. Antonaccio. 1993. Involvement of the "tethered ligand" receptor in thrombin-induced endothelium-mediated relaxations, Am. J. Physiol. 265:H1744-H1749.
32. Kim, D.W., F. Wang, S. Ramakrishnan, D.L. Scott, T.M. Hensler, W.C. Thompson, and D.H. Carney. 1994. Mouse fibroblasts defective in thrombin mitogenesis possess functional proteolytically activated receptor for thrombin: requirements for a second signaling pathway. J. Cell. Physiol. 160:573-584
33. Zucker, S., C. Conner, B. DiMassimo, H. Ende, and W. Bahou. 1995. Thrombin induces cell surface activation of gelatinase A in vascular endothelial cells: physiological regulation of angiogenesis. J. Biol Chem. 270:23730-23738.
34. Vouret-Craviari, V., E. Van Obberghen-Schilling, V. Rasmussen, A. Pavirani, J. Lecocq, and J. Pouyssegur. 1991. Synthetic alpha-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis Mol. Cell. Biol 3.95-102.
35. McGowan, E., and T. Detwiller. 1987. Modified platelet responses to thrombin Evidence for two types or receptors or coupling mechanisms. J. Biol. Chem. 261:739-746.
36. Chambard, J., S. Paris, G L'Allemain, and J. Pouyssegur 1987. Two growth factor signalling pathways in fibroblasts distinguished by pertussis toxin. Nature (Lond ) 326:800-803.
37. Nystedt, S., K. Emilsson, C Wahlestedt, and J. Sundelin. 1994. Molecular cloning of a potential proteinase activated receptor. Proc. Natl. Acad. Sci., USA. 91:9208-9212.
38. Coughlin, S.R. 1994. Protease-activated receptors start a family. Proc Natl. Acad Sci USA. 91 9200-9202.
39. Pustell, J , and F. Kafatos. 1986. A convenient and adaptable microcomputer environment for DNA and protein sequence manipulation and analysis. Nucleic Acids. 14:479-488.
40. Nystedt, S., A.K. Larsson, H. Aberg, and J. Sundelin. 1995. The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression. J. Biol Chem. 270:5950-5955.
41. Bahou, W., A. Campbell, and M. Wicha. 1992. cDNA cloning and molecular characterization of MSE55: a novel human serum constituent protein that displays bone marrow stromal endothelial cell-specific expression. J. Biol Chem. 267:13986-13992.
42. Nystedt, S., K. Emilsson, A.-K. Larsson. B. Strombcck, and J. Sundelin. 1995. Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur. J. Biochem. 232:84-89.
43. Bahou, W.F., C.L. Potter, and H. Mirza. 1994. The VLA-2 (alpha 2 beta 1) I domain functions as a ligand-specific recognition sequence for endothelial cell attachment and spreading: molecular and functional characterization. Blood 84:3734-3741.
44. Mossman, J. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxic assays. J. Immunol. Methods 65:55-63.
45. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450.
46. Hein, L., K. Ishii, S.R. Coughlin, and B.K. Kobilka. 1994. Intracellular targeting and trafficking of thrombin receptors. A novel mechanism for resensitization of a G protein-coupled receptor. J. Biol. Chem. 269:27719-27726.
47. Woolkalis, M.J., T.M. DeMelfi, Jr., N. Blanchard, J.A. Hoxie, and L.F. Brass. 1995. Regulation of thrombin receptors on human umbilical vein endothelial cells. J. Biol Chem. 270:9868-9875.
48. Brown, J.K., C.A Jones, C.L. Tyler, S.J. Ruoss, T. Hartmann, and G H. Caughey. 1995. Tryptase-induced mitogenesis in airway smooth muscle cells. Potency, mechanisms, and interactions with other mast cell mediators. Chest. 107:95S-96S.
49. Morris, G.M., J R Hadcock, and C.C. Malbon. 1991. Cross-regulation between G-protein-coupled receptors. Activation of beta 2-adrenergic receptors increases alpha 1-adrenergic receptor mRNA levels. J. Biol. Chem. 266: 2233-2238.
50. 2-adrenergic receptors. J. Biol Chem 268:7949-7957.
51. Smith, J.A., C. Webb, J. Holford, and G.M. Burgess. 1995. Signal transduction pathways for B1 and B2 bradykinin receptors in bovine pulmonary artery endothelial cells. Mol Pharmacol 47:525-534.
52. Ishii. K., L. Hein, B. Kobilka, and S.R. Coughlin. 1993. Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J. Biol. Chem. 268:9780-9786.
53. Zacharias, U., Y. Xu, J. Hagege, J.D. Sraer, L.F. Brass, and E. Rondeau. 1995. Thrombin, phorbol ester, and cAMP regulate thrombin receptor protein and mRNA expression by different pathways. J. Biol. Chem. 270:545-550.
54. Molino, M., N. Blanchard, E. Belmonte. A.P. Tarver, C. Abrams, J A. Hoxie, C. Cerletti, and L.F. Brass 1995. Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol. Chem. 270:11168-11175.
55. Bahou, W., C. Potter, and A. Wong. 1992. Molecular characterization of the human thrombin receptor gene. Blood 80(Suppl. 1):265a.